Sr. Mgr, Hospital & Institutional Marketing

Parsippany, NJ (On-site)

$146K/yr – $201K/yrSenior Level4+ years expFull time

Posted 6 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own hospital-facing access and brand execution, coordinating with Sales, Market Access, and field teams to shape physician, administrator, and value-analytic engagement across IDNs and acute-care settings.

  • Hospital Strategy & Execution: drive cross-channel plans for IDNs, health systems, and academic centers with aligned messaging.
  • Tools & Materials: develop KAM/ABD support tools, access dossiers, and education resources that are compliant and field-ready.
  • Feedback & Analytics: gather field insights, monitor P&T trends, and track access and utilization to optimize programs.

Job Description

Responsibilities

  • Support the development of execution of hospital marketing strategies aligned with brand initiatives
  • Drive strategic planning and tactical implementation for hospital-based customer segments, including IDNs, health systems, academic medical centers, community hospitals, infusion centers and other acute-care settings
  • Assist in the development of positioning, messaging, and promotional strategies tailored to hospital stakeholders, including physicians, pharmacists, nurses, infection prevention, administrators, and value analysis committees
  • Ensure consistent execution of brand strategy across all hospital-facing channels and customer touchpoints
  • Partner closely with Sales, Market Access and field account teams, to support aligned strategy and execution
  • Collaborate with Brand Marketing, Sales, Medical Affairs, and Commercial Operations to ensure consistent and coordinated customer engagement
  • Support field-based account teams (e.g., KAMs/ABDs) through development of tools, resources, and customer-facing materials
  • Coordinate with internal stakeholders and external agency partners to support timely execution of projects and initiatives
  • Assist in developing and maintaining access-focused materials, including dossiers and Pharmacy and Therapeutics kits, account tools, and customer education resources
  • Ensure materials are compliant, customer-focused, and effectively support field execution

Requirements

  • Bachelor’s degree required
  • 4+ years of experience in pharmaceutical marketing or related commercial roles
  • Experience supporting hospital, IDN, or institutional customers preferred
  • 20% travel

Preferred

  • Advanced degree preferred
  • Experience supporting hospital, IDN, or institutional customers preferred
  • Experience working with or supporting field-based teams (e.g., KAMs, SAMs) preferred
CorMedix Therapeutics logo

CorMedix Therapeutics

4.0 Glassdoor

CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company is focused on developing its lead product DefenCathTM, a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. DefenCath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product (QIDP), and the original New Drug Application (NDA) received priority review in recognition of its potential to address an unmet medical need. For more information, visit: www.cormedix.com.

Founded in 2006
Berkeley Heights, New Jersey, USA
180 employees (6 in marketing)
0% recommend to a friend
100% CEO approval

Traffic Signals

Monthly Visitors
12.4K
Traffic Source Mix
Search
46.4%
Direct
36.2%
Referral
6%
Social
10%
Paid
1.2%

Headcount Trend

Current headcount: ~180

Marketing Team

Marketing Team Size
6 (3% of company)
Marketing Roles Posted (Last 30 Days)
3

Funding

Total Funding
$96.5M
Last Raise
$85M
Post IPO Equity, 12 months ago

Funding History

  • Jun 2025
    Post IPO Equity • $85M
  • Nov 2017
    Post IPO Equity • $5M
  • Oct 2013
    Post IPO Equity • $3M

Recent News